We are pleased to announce the editorial structure 2024 for Hypertension Research, as we strive towards globalization in 2024. Hypertension is the biggest risk factor for cardiovascular diseases, yet it is still poorly controlled and there are large regional differences globally.

Hypertension Research is the official journal of the Japanese Society of Hypertension with a 46-year history. It has grown significantly with the support of many domestic and international hypertension researchers. In 2023, the number of submissions exceeded 900 papers, and the Impact Factor 2022 holds at 5.4. The 45th Annual Scientific Meeting of the Japanese Society of Hypertension (JSH2023 OSAKA) was held, with 41 papers submitted. A total of 22 online Fast Track papers were published in the Special Issue – JSH2023 Fast Track in January 2024. We would like to thank the authors, reviewers, Associate Editors, JSH members, readers, and the publisher Springer Nature for their contributions.

The annual Update and Perspectives will be held again this year. This is a popular project in which articles accepted for publication in Hypertension Research during the year are summarized for readers by dividing them into the following themes.

  1. 1.

    Digital Hypertension

  2. 2.

    BP variability/Phenomenon

  3. 3.

    BP management/BP monitoring

  4. 4.

    Renal Denervation

  5. 5.

    DM/Metabolism/Liver

  6. 6.

    Vascular

  7. 7.

    Kidney

  8. 8.

    Heart

  9. 9.

    Brain/Stroke/Dementia

  10. 10.

    Salt/Na/Nutrition

  11. 11.

    Preeclampsia/Pregnant/offspring

  12. 12.

    Primary Aldosteronism/MR/Adrenal

  13. 13.

    Uric Acid

  14. 14.

    Basic

Now, let me introduce highly reliable and cutting-edge members of the Editorial Board to readers (Supplementary file 1).

Comprising seasoned veterans to young researchers, they hail from 21 countries internationally, actively contributing to submissions, peer reviews, and more. We sincerely appreciate their valuable contributions.

We are currently focusing on five themes and publishing special issues (Fig. 1); Asian Study: Current evidence and perspectives for hypertension management in Asia [1], Renal Denervation and Sympathetic Nerve System [2], Digital Hypertension [3], Home Blood Pressure-Centered Management of Hypertension [4] and including a new theme “Guideline Special Issue” for the JSH Guideline. In Europe, the ESH 2023 guidelines had been announced [5], and Japan has also commenced the revision of its guidelines:

Fig. 1
figure 1

Special focus of Hypertension Research

Full size image

Asian Study: Current evidence and perspectives for hypertension management in Asia https://www.nature.com/collections/hdfajcbdge.

Renal Denervation and Sympathetic Nerve System https://www.nature.com/collections/aifhdaefbe.

Digital Hypertension https://www.nature.com/collections/hjgcahdbdc.

Home Blood Pressure-Centered Management of Hypertension https://www.nature.com/collections/fccajbccef.

Guidelines for the Management of Hypertension https://www.nature.com/collections/jjgccghjff.

We hope that Hypertension Research will become a platform for the dissemination and exchange of academic activities and research information for healthcare and medical professionals and researchers around the world. If you are interested in Hypertension Research, we also warmly welcome Guest Editors. We look forward to your valuable contributions.

Call for Paper https://www.nature.com/hr/call-for-paper.